Literature DB >> 19234528

ING function in apoptosis in diverse model systems.

Sitar Shah1, Heather Smith, Xiaolan Feng, Derrick E Rancourt, Karl Riabowol.   

Abstract

Genetic studies in model organisms have shown that programmed cell death (apoptosis) plays a significant role during development, where a deficiency in apoptosis results in severe and diverse diseases. Dysregulation of apoptosis also contributes to a variety of human diseases, such as cancer and autoimmune diseases. ING family proteins (ING1-ING5) are involved in many cellular processes, and appear to play a significant role in apoptosis. Loss or downregulation of ING protein function is frequently observed in different tumour types, many of which are resistant to apoptosis, thus warranting their classification as type II tumour suppressors. Several different in vitro and in vivo models have explored the role of ING proteins in regulating apoptosis. In this review, we discuss the progress that has been made in understanding ING protein function in apoptosis using in vitro studies and Mus musculus, Xenopus laevis, and Caenorhabditis elegans experimental models, with an emphasis on ING1 and ING3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234528     DOI: 10.1139/O08-107

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  17 in total

Review 1.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

2.  The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.

Authors:  Jun Liu; Yongping Lin; Haihong Yang; Qiuhua Deng; Guoqin Chen; Jianxing He
Journal:  Tumour Biol       Date:  2011-07-22

3.  Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.

Authors:  Xiao-Bo Guo; Chang-Qing Jing; Le-Ping Li; Li Zhang; Yu-Long Shi; Jin-Shen Wang; Jing-Lei Liu; Chen-Sheng Li
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

4.  Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.

Authors:  Nashi Widodo; Didik Priyandoko; Navjot Shah; Renu Wadhwa; Sunil C Kaul
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

Review 5.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

6.  ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.

Authors:  Amal Almami; Samar A Hegazy; Arash Nabbi; Mohammed Alshalalfa; Asma Salman; Hatem Abou-Ouf; Karl Riabowol; Tarek A Bismar
Journal:  Tumour Biol       Date:  2016-01-23

7.  Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).

Authors:  Xiaohan Li; Qun Zhang; Mingming Zhang; Yusong Luo; Yaping Fu
Journal:  Histol Histopathol       Date:  2019-12-30       Impact factor: 2.303

8.  ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma.

Authors:  Xiaohan Li; Keiji Kikuchi; Yasuo Takano
Journal:  J Oncol       Date:  2010-10-28       Impact factor: 4.375

9.  Proliferating cell nuclear antigen (PCNA) interactions in solution studied by NMR.

Authors:  Alfredo De Biasio; Ramón Campos-Olivas; Ricardo Sánchez; Jorge P López-Alonso; David Pantoja-Uceda; Nekane Merino; Maider Villate; Jose M Martin-Garcia; Francisco Castillo; Irene Luque; Francisco J Blanco
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

10.  Src regulates the activity of the ING1 tumor suppressor.

Authors:  Lisa Yu; Satbir Thakur; Rebecca Yy Leong-Quong; Keiko Suzuki; Andy Pang; Jeffrey D Bjorge; Karl Riabowol; Donald J Fujita
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.